To confirm the relevance of Regnase-1 deficiency for AML pathogenesis, we undertook RNA-seq-based genome-wide gene expression profiling using CD34− HSCs collected from control Reg1flox/flox and Reg1Δ/Δ mice BM. This evidence concerns the gene ZC3H12A and acute myeloid leukemia.